Research shows ability to do next-generation sequencing for patients with advanced cancers
Sequencing spells out, or decodes, the billions of letters of DNA and other genomic data so that clinicians can discover what genetic changes might lead to cancer. Better optics and faster computers, which are the hallmarks of today’s Next Generation Sequencing (NGS), are leading to genomic analysis that enables development of new drugs that target specific genetic mutations. However, because patients’ tumors often contain multiple abnormalities, their cancer often progresses beyond initial targeted therapies…